论文部分内容阅读
近年作者用大剂量马利兰(Myleran)间歇诱导慢性粒细胞白血病(慢粒)缓解,取得了较好的效果,并与常规量的治疗结果进行了比较,简报如下。 临床资料 大剂量组(研究组)系1986年2月～1987年9月确诊住院病例,共10例,其中初治8例。复治2例。 常规量组(对照组)系1983年5月～1986年1月的慢性住院病例,亦为10例,其中初治7例,复治3例。
In recent years, the author used high-dose Myleran intermittent induction of chronic myeloid leukemia (CML) to alleviate, and achieved good results, and compared with the conventional amount of treatment results, the briefing is as follows. Clinical data of high-dose group (study group) was diagnosed in February 1986 ~ September 1987 hospitalized cases, a total of 10 cases, including initial treatment in 8 cases. Retreatment in 2 cases. The conventional dose group (control group) was a chronic inpatient from May 1983 to January 1986, and 10 patients were also included, of whom 7 were newly diagnosed and 3 were retreated.